N0 (N=182) |
N1 (N=34) |
N2 (N=14) |
N3 (N=1) |
P-value | |
---|---|---|---|---|---|
pathologic_T | |||||
T1 | 182 (100%) | 34 (100%) | 14 (100%) | 1 (100%) | <0.001 |
pathologic_M | |||||
M0 | 121 (66.5%) | 24 (70.6%) | 7 (50.0%) | 0 (0%) | 0.0789 |
M1 | 1 (0.5%) | 2 (5.9%) | 0 (0%) | 0 (0%) | |
MX | 60 (33.0%) | 8 (23.5%) | 7 (50.0%) | 1 (100%) | |
pathologic_stage | |||||
Stage I | 181 (99.5%) | 0 (0%) | 0 (0%) | 0 (0%) | <0.001 |
Stage IV | 1 (0.5%) | 2 (5.9%) | 0 (0%) | 0 (0%) | |
Stage II | 0 (0%) | 31 (91.2%) | 0 (0%) | 0 (0%) | |
Stage III | 0 (0%) | 0 (0%) | 14 (100%) | 1 (100%) | |
Missing | 0 (0%) | 1 (2.9%) | 0 (0%) | 0 (0%) | |
Age (years) | |||||
Mean (SD) | 66.9 (8.93) | 64.8 (9.76) | 65.5 (10.3) | 60.0 (NA) | 0.956 |
Median [Min, Max] | 68.0 [39.0, 88.0] | 63.0 [41.0, 79.0] | 64.5 [49.0, 81.0] | 60.0 [60.0, 60.0] | |
Missing | 4 (2.2%) | 1 (2.9%) | 0 (0%) | 0 (0%) | |
gender | |||||
FEMALE | 99 (54.4%) | 15 (44.1%) | 9 (64.3%) | 1 (100%) | 0.426 |
MALE | 83 (45.6%) | 19 (55.9%) | 5 (35.7%) | 0 (0%) |